|
1
|
Nguyen DX, Paula DB and Massagué J:
Metastasis: from dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fidler IJ: Critical factors in the biology
of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial
award lecture. Cancer Res. 50:6130–6138. 1990.PubMed/NCBI
|
|
3
|
Talmadge JE and Fidler IJ: AACR centennial
series: the biology of cancer metastasis: historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pantel K and Brakenhoff RH: Dissecting the
metastatic cascade. Nat Rev Cancer. 4:448–456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Braun S, Vogl FD, Naume B, et al: A pooled
analysis of bone marrow micrometastasis in breast cancer. N Engl J
Med. 353:793–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hüsemann Y, Geigl JB, Schubert F, et al:
Systemic spread is an early step in breast cancer. Cancer Cell.
13:58–68. 2008.
|
|
8
|
Lin H, Balic M, Zheng S, Datar R and Cote
RJ: Disseminated and circulating tumor cells: Role in effective
cancer management. Crit Rev Oncol Hematol. 77:1–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Flatmark K, Borgen E, Nesland JM, et al:
Disseminated tumor cells as a prognostic biomarker in colorectal
cancer. Br J Cancer. 104:1434–1439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sugimura H, Nichols FC, Yang P, et al:
Survival after recurrent non small-cell lung cancer after complete
pulmonary resection. Ann Thorac Surg. 83:409–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feld R, Rubinstein LV and Weisenberger TH:
Sites of recurrence in resected stage I non-small-cell lung cancer:
a guide for future studies. J Clin Oncol. 2:1352–1358.
1984.PubMed/NCBI
|
|
12
|
Gutt R, Liauw SL and Weichselbaum RR:
Adjuvant radiotherapy for resected pancreatic cancer: a lack of
benefit or a lack of adequate trials? Nat Clin Pract Gastroenterol
Hepatol. 6:38–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schabel FM Jr: Rationale for adjuvant
chemotherapy. Cancer. 39:2875–2882. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Visbal AL, Leighl NB, Feld R and Shepherd
FA: Adjuvant chemotherapy for early-stage non-small cell lung
cancer. Chest. 128:2933–2943. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Navin N, Kendall J, Troge J, et al: Tumour
evolution inferred by single-cell sequencing. Nature. 472:90–94.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Campbell PJ, Yachida S, Mudie LJ, et al:
The patterns and dynamics of genomic instability in metastatic
pancreatic cancer. Nature. 467:1109–1113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Greaves M and Maley CC: Clonal evolution
in cancer. Nature. 481:306–313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malanchi I, Santamaria-Martinez A, Susanto
E, et al: Interactions between cancer stem cells and their niche
govern metastatic colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Navab R, Strumpf D, Bandarchi B, et al:
Prognostic gene-expression signature of carcinoma-associated
fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci USA.
108:7160–7165. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mink SR, Vashistha S, Zhang W, et al:
Cancer-associated fibroblasts derived from EGFR-TKI-resistant
tumors reverse EGFR pathway inhibition by EGFR-TKIs. Mol Cancer
Res. 8:809–820. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang W, Li Q, Yamada T, et al: Crosstalk
to stromal fibroblasts induces resistance of lung cancer to
epidermal growth factor receptor tyrosine kinase inhibitors. Clin
Cancer Res. 15:6630–6638. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Serebriiskii I, Castelló-Cros R, Lamb A,
Golemis EA and Cukierman E: Fibroblast-derived 3D matrix
differentially regulates the growth and drug-responsiveness of
human cancer cells. Matrix Biol. 27:573–585. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wilmanns C, Fan D, O’Brian CA, Bucana CD
and Fidler IJ: Orthotopic and ectopic organ environments
differentially influence the sensitivity of murine colon carcinoma
cells to doxorubicin and 5-fluorouracil. Int J Cancer. 52:98–104.
1992. View Article : Google Scholar
|
|
24
|
Kim S-H, Choi S, Cho YB, et al:
Differential gene expression during colon-to-lung metastasis. Oncol
Rep. 25:629–36. 2011.PubMed/NCBI
|
|
25
|
Gilson N, Honoré O, Detry O, et al:
Surgical management of hepatic metastases of colorectal origin.
Acta Gastroenterol Belg. 72:321–326. 2009.PubMed/NCBI
|
|
26
|
Kjeldsen BJ, Kronborg O, Fenger C and
Jorgensen OD: The pattern of recurrent colorectal cancer in a
prospective randomized study and the characteristics of diagnostic
tests. Int J Colorectal Dis. 12:329–334. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fidler IJ and Kripke ML: Genomic analysis
of primary tumors does not address the prevalence of metastatic
cells in the population. Nat Genet. 34:232003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jones S, Chen WD, Parmigiani G, et al:
Comparative lesion sequencing provides insights into tumor
evolution. Proc Natl Acad Sci USA. 105:4283–4288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fidler IJ: The pathogenesis of cancer
metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003.
|
|
30
|
Psaila B and Lyden D: The metastatic
niche: adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Klein CA: Parallel progression of primary
tumours and metastases. Nat Rev Cancer. 9:302–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gupta GP and Massague J: Cancer
metastasis: building a frame-work. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamamoto J, Sugihara K, Kosuge T, et al:
Pathologic support for limited hepatectomy in the treatment of
liver metastasis from colorectal cancer. Ann Surg. 221:74–78. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park JS, Kim HK, Choi YS, et al: Outcomes
after repeated resection for recurrent pulmonary metastases from
colorectal cancer. Ann Oncol. 21:1285–1289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suriawinata AA and Thung NS: Liver.
Histology for Pathologists. Mills SE: 3rd edition. Lippincott
Williams & Wilkins; pp. 685–703. 2007
|
|
36
|
Colby TV, Leslie KO and Yousem SA: Lung.
Histology for Pathologists. Mills SE: 3rd edition. Lippincott
Williams & Wilkins; pp. 473–504. 2007
|
|
37
|
Stelzer G, Inger A, Olender T, et al:
GeneDecks: paralog hunting and gene-set distillation with GeneCards
annotation. OMICS. 13:477–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fidler IJ: Critical factors in the biology
of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial
award lecture. Cancer Res. 50:6130–8. 1990.PubMed/NCBI
|
|
39
|
Kopitz C, Gerg M, Bandapalli OR, et al:
Tissue inhibitor of metalloproteinases-1 promotes liver metastasis
by induction of hepatocyte growth factor signaling. Cancer Res.
67:8615–8623. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Stein U, Walther W, Arlt F, et al: MACC1,
a newly identified key regulator of HGF-MET signaling, predicts
colon cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee ES, Son DS, Kim S-H, et al: Prediction
of recurrence-free survival in postoperative non-small cell lung
cancer patients by using an integrated model of clinical
information and gene expression. Clin Cancer Res. 14:7397–7404.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Koh KH, Rhee H, Kang HJ, et al:
Differential gene expression profiles of metastases in paired
primary and metastatic colorectal carcinomas. Oncology. 75:92–101.
2008. View Article : Google Scholar : PubMed/NCBI
|
